Author(s) :

Sarmad Ahmad.

Volume/Issue :

Abstract :

Ribavirin is a powerful antiviral medication. It exhibits viability across a wide range of viral diseases. However, hepatically compromised patients face trouble with modified drug digestion. To address this problem, inhalational ribavirin formulations or dose structures have arisen as a promising methodology, offering designated drug delivery, decreased fundamental openness, and worked on helpful results. This article thoroughly analyzes the turn of events, detailing methodologies, pharmacological experiences, safety contemplations, and future capability of inhalational ribavirin, zeroing in on its necessary job in patients with compromised liver function

No. of Downloads :

3